Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Liposomal vs Standard Bupivacaine for Post-Rhinoplasty Pain

Official title: Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia: A Randomized Clinical Trial

Run by Washington University School of Medicine · NCT07689162 · Data updated 2026-11-12

This study tests whether liposomal bupivacaine provides better pain control after rhinoplasty than standard bupivacaine.

More Pain, Postoperative trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedJune 2027
Study endsJuly 2027
Registry record updatedAugust 18, 2026
Trial IDNCT07689162 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) undergoing open rhinoplasty (primary, revision, functional, or cosmetic) with any grafting type.

Probably not a fit

Patients with contraindications to local anesthetics or those with chronic pain requiring ongoing analgesics may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this Phase 2 interventional trial, adults undergoing open rhinoplasty are randomly assigned to receive either liposomal bupivacaine or standard bupivacaine as a nerve block during surgery. Pain levels are tracked for several days after the procedure, and safety and recovery are monitored. The goal is to determine which formulation more effectively reduces postoperative pain and supports smoother healing. The study is conducted at Washington University School of Medicine in St. Louis.

Why it matters

Potential benefit: If liposomal bupivacaine proves more effective, patients may experience less pain and faster recovery after rhinoplasty.

How similar studies have gone: Previous studies in other surgical settings have shown varying benefits of liposomal bupivacaine; results in rhinoplasty specifically are being evaluated in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (≥18 years) undergoing open rhinoplasty of any indication or complexity (e.g., primary, revision, functional, or cosmetic), including autologous grafting of any type (e.g., septal or costal cartilage) or cadaveric grafting.

Exclusion Criteria:

* Chronic pain condition requiring ongoing or scheduled analgesic therapy, or any diagnosis associated with chronic pain (e.g., fibromyalgia, chronic headache/migraine, neuropathic pain, complex regional pain syndrome), long-term opioid use (≥3 months, any agent), allergy or contraindication to local anesthetics, acetaminophen, ibuprofen / NSAIDs, tramadol, ketamine, Medrol (methylprednisolone) dose pack
* Concurrent non-nasal surgery planned

Where it's running

  • Washington University
    St Louis, Missouri, United States
    Recruiting

Study contacts

  • Principal investigator: Matthew Wu, MD — Washington University School of Medicine
  • Study coordinator: Matthew Wu, MD
  • Email: mjwu@wustl.edu
  • Phone: 314-362-0524

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.